JAGX

Jaguar Health, Inc. JAGX

JAGX
Jaguar Health, Inc. TNXP
Tonix Pharmaceuticals Holding Corp. SONN
Sonnet BioTherapeutics Holdings, Inc. TRAW
Traws Pharma, Inc. PALI
Palisade Bio, Inc. IBIO
iBio, Inc. OCGN
Ocugen, Inc. BNGO
Bionano Genomics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode JAGX TNXP SONN TRAW PALI IBIO OCGN BNGO
6M -62.84 % 25.53 % 241.86 % 50.50 % 186.94 % -34.06 % 147.68 % -56.86 %
YTD -92.40 % -32.52 % 175.63 % -65.28 % 7.53 % -67.30 % 90.00 % -87.27 %
1Y -93.43 % 41.27 % -4.75 % -39.92 % -41.35 % -69.57 % 80.02 % -90.72 %
3Y -99.96 % -99.79 % -98.03 % -83.95 % -97.10 % -98.37 % 4.27 % -99.86 %
5Y -99.99 % -100.00 % -99.97 % -97.03 % -99.93 % -99.92 % 404.42 % -99.45 %
10Y -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.98 % -99.36 % -96.83 %
From the beginning -100.00 % -100.00 % -100.00 % -100.00 % -100.00 % -99.98 % -99.76 % -96.83 %

Dividend